THE PROJECTThe U-PGx consortium will address major challenges and obstacles for implementation of PGx testing in patient care, taking into account the diversity of healthcare systems and citizens across Europe. Specifically, U-PGx will investigate if the emerging approach of pre-emptive genotyping of an entire panel of important PGx markers is cost-effective and results in a better outcome for patients.
|
SHARED EUROPEAN GUIDELINESMaintenance and dissemination of pharmacogenomics guidelines in the European Union
|
IMPLEMENTATION AND EVALUATIONClinical implementation and outcome evaluation of pre-emptive pharmacogenomics in a multitude of European countries
|
ENABLING TECHNOLOGIES
Development of powerful and barrier-free clinical decision support systems and novel pharmacogenomics methodologies
|
COMMUNICATION AND EDUCATION
Development of a program to reach out to patients, health care professionals, regulatory agencies, politics and health insurance organisations
|